Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
Bold Capital Partners
AddedFeb 13, 2024
UpdatedJun 28, 2026
Bold Capital Partners

Bold Capital Partners

Operating

Bold Capital Partners, co-founded by Peter Diamandis, is a venture capital firm investing in tech companies.

Location
Santa Monica, CA, US
Founded
2015
Firm
Compare
Portfolio
Fundraising
Employees
News
Website

Investments

Gallant
Gallant

Total Raised

$15M

Rounds

1

Series A$15MJanuary 2024
Liquid AI
Liquid AI

Total Raised

$43.2M

Rounds

2

Seed$37.6MDecember 2023
Mighty Buildings
Mighty Buildings

Total Raised

$153.8M

Rounds

10

Series B$52MSeptember 2023
Viome
Viome

Total Raised

$276M

Rounds

8

Series C$86.5MAugust 2023
Series C$67MOctober 2022
Crowdz
Crowdz

Total Raised

$28.5M

Rounds

6

Series B$14.7MJune 2023
Solarea Bio
Solarea Bio

Total Raised

$26.2M

Rounds

4

Series B$15MMay 2023
Switch Therapeutics
Switch Therapeutics

Total Raised

$52M

Rounds

1

Series A$52MMarch 2023
Colossal Biosciences
Colossal Biosciences

Total Raised

$235.5M

Rounds

5

Series B$150MJanuary 2023
Series A$60MMarch 2022
Dreamscape Learn
Dreamscape Learn

Total Raised

$20M

Rounds

1

Series A$20MJanuary 2023
Deciduous Therapeutics
Deciduous Therapeutics

Total Raised

$16.5M

Rounds

3

Seed$10MDecember 2022
Earth Force Technologies
Earth Force Technologies

Total Raised

$8.6M

Rounds

1

Seed$8.6MNovember 2022
Bionaut Labs
Bionaut Labs

Total Raised

$63.2M

Rounds

5

Series B$43.2MNovember 2022
Gameto
Gameto

Total Raised

$40M

Rounds

4

Series Unknown$17MSeptember 2022
Series A$20MJanuary 2022
AliveCor
AliveCor

Total Raised

$154.3M

Rounds

9

Series FAugust 2022
Insilico Medicine
Insilico Medicine

Total Raised

$401.3M

Rounds

11

Series D$35MAugust 2022
Series D$60MJune 2022
Curebase
Curebase
Series B

Total Raised

$57.5M

Rounds

5

Series B$40MMay 2022
Omeat
Omeat

Total Raised

$40M

Rounds

2

Series A$36.5MApril 2022
Pyka
Pyka

Total Raised

$48.1M

Rounds

3

Series A$37MApril 2022
Verana Networks
Verana Networks

Total Raised

$52.5M

Rounds

5

Series B$28MApril 2022
Rugged Robotics
Rugged Robotics

Total Raised

$11.9M

Rounds

3

Series A$9.4MMarch 2022
ParkourSC
ParkourSC

Total Raised

$75M

Rounds

7

Series Unknown$26MMarch 2022